This review emphasizes that despite higher baseline risks and bleeding concerns, elderly patients with ACS benefit significantly from guideline-directed medical therapies and revascularization, highlighting the need to avoid age-based undertreatment.
Guideline-directed therapy should be prioritized in elderly ACS patients; reinforces benefits in contemporary American and European guidance.
The elderly constitute a sizeable proportion of the acute coronary syndrome (ACS) population, and this population is continually increasing in number. Guideline-directed therapy is frequently underutilized in the elderly due to concerns about patient safety. However, studies suggest that this subgroup could benefit from many of the conventional and newer therapies available. This paper reviews current literature in the context of contemporary American and European guidance.
No takes yet. Share an insight, caveat, or question.
McCune et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: